Trademark Overview
On Monday, July 22, 2024, a trademark application was filed for ABZELECT with the United States Patent and Trademark Office. The USPTO has given the ABZELECT trademark a serial number of 98660702. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, February 3, 2025. This trademark is owned by Abzena (UK) Limited. The ABZELECT trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceuticals; Pharmaceutical compositions; Pharmaceutical preparations; Chemical preparations for medical or pharmaceutical purposes; Chemico-pharmaceutical preparations; Chemicals for pharmaceutical use; Vaccines; Pharmaceutical preparations for skin care; none of the aforementioned products being finished pharmaceutical products administered to patients for the treatment of Parkinson's disease or other diseases or disorders of the central nervous system
Chemicals for use in manufacturing pharmaceuticals; Chemical preparations for use in the manufacture of pharmaceuticals; Chemicals for use in the pharmaceutical industry; Preservatives for pharmaceuticals; Flavour improvers for pharmaceutical products; Intermediates for pharmaceuticals
Scientific and technological services and research and design relating thereto; Industrial analysis and research services; All in relation to pharmaceutical and medical purposes; Product design; Pharmaceutical research services; Pharmaceutical product evaluation; Inspection of pharmaceuticals; Testing of pharmaceuticals; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Provision of scientific information; Compilation and provision of toxicological information; Assessing toxicological information in relation to risks; Assessing chemical information in relation to risks; Provision of scientific information relating to the chemical industry; none of the aforementioned services relating to finished pharmaceutical products administered to patients for the treatment of Parkinson's disease or other diseases or disorders of the central ne...
